[PDF][PDF] Drug repurposing” policies and statutes: lessons from the COVID-19 pandemic: a review

S Ravi, S Jadhav, R Ghooi - Indian J Pharm Educ Res, 2023 - archives.ijper.org
Introduction: Repurposed drugs are not eligible for patent protection in India vide Sec 3 (d)
of the Indian Patent Act, 1970. The data generated to establish the therapeutic efficacy of the …

Clinical Trials of COVID-19 Therapeutics and Vaccines: History, Current Status, and Limitations

CH Perry, HÖ Kılgöz, Ş Tüzmen - COVID-19, 2022 - taylorfrancis.com
In less than two decades, the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-
2), the virus that triggered the COVID-19 pandemic, has caused the world's third coronavirus …